ClinicalTrials.Veeva

Menu

Cocaine Abuse and Attention Deficit Disorder - 3

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status

Completed

Conditions

Cocaine-Related Disorders

Treatments

Drug: Bupropion

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000268
NIDA-09236-3
P50-09236-3

Details and patient eligibility

About

The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder

Full description

To evaluate the safety and efficacy of methylphenidate and bupropion in treating individuals with adult Attention Deficit Disorder.

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

current adult ADHD current cocaine dependence

Exclusion criteria

no current major depression

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems